- Rizatriptan
- Rizatriptan benzoate
- 144036-17-9Benzoic acid,3-(cyclopentyloxy)-4-methoxy-
- 14404-25-2Rhodium,tetracarbonyldi-m-chlorodi-
- 144043-17-43-Pyrrolidinamine,N-methyl-1-(phenylmethyl)-, (3R)-
- 144043-20-93-Pyrrolidinamine,N,N-dimethyl-, hydrochloride (1:2), (3S)-
- 14404-33-2Ruthenate(2-),aquapentachloro-, potassium (1:2), (OC-6-21)-
- 14404-59-2Tin chloride fluoride(SnClF) (7CI,8CI,9CI)
- 144049-91-2Butanoic acid,(6R,7R,8R,14aS)-5,6,7,8-tetrahydro-2,3-dimethoxy-6,7-dimethyl-1-oxo-1H,14H-benzo[1,8]cycloocta[1,2,3-cd][1,3]dioxolo[4,5-g]benzofuran-8-ylester (9CI)
- 14405-03-9Acetamide,2-chloro-N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-
- 14405-43-7Gallium,tris(2,4-pentanedionato-kO,kO')-, (OC-6-11)- (9CI)
- 14405-45-9Indium,tris(2,4-pentanedionato-kO2,kO4)-, (OC-6-11)-
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
Rizatriptan |
EINECS | N/A |
| CAS No. | 144034-80-0 | Density | 1.21 g/cm3 |
| PSA | 49.74000 | LogP | 1.91180 |
| Solubility | water: 42 mg/mL | Melting Point |
178-180 °C |
| Formula | C15H19N5 | Boiling Point | 504.8 °C at 760 mmHg |
| Molecular Weight | 269.349 | Flash Point | 259.1 °C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Risk Codes | N/A | |
| Molecular Structure |
|
Hazard Symbols | N/A |
| Synonyms |
3-[2-(Dimethylamino)ethyl]-5-(1H-1,2,4-triazol-1-ylmethyl)indole;MK 462 free base;N,N-Dimethyl-2-[5-(1H-1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine;Risatriptan;Rizatriptan; |
Article Data | 21 |
Rizatriptan Chemical Properties
Rizatriptan (144034-80-0) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).
Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.
Rizatriptan(144034-80-0) is available only by prescription in the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv) and Israel (as Rizalt).
The density of Rizatriptan(144034-80-0) is 1.21 g/cm3 and it has a melting point of 178-180°C. The boiling point is 504.8 °C at 760 mmHg. The refractive index is about 1.645. Its flash point is 259.1 °C.
The chemical synonyms of Rizatriptan(144034-80-0) are n,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-1h-indole-3-ethanamine;n,n-dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1h-indol-3-yl]ethanamine;RIZATRIPTAN
The molecular structure of Rizatriptan(144034-80-0):
Rizatriptan Uses
What can I do for you?
Get Best Price
